Re: Why are you invested in RVX
|
3
|
Resverlogix Corp.
|
Jun 18, 2019 04:03PM
|
Re: Zenith funding???
|
4
|
Zenith Epigenetics
|
Jun 25, 2019 10:59AM
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
4
|
Zenith Epigenetics
|
Jun 27, 2019 10:43AM
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 25, 2019 03:22PM
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
4
|
Zenith Epigenetics
|
Jul 26, 2019 10:50AM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 11:32AM
|
Re: TD & Zen over the weekend..
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 02:46PM
|
Re: New PP on Aug 13
|
7
|
Zenith Epigenetics
|
Aug 20, 2019 10:22AM
|
Re: Seeking Alpha mention
|
2
|
Resverlogix Corp.
|
Aug 23, 2019 08:46AM
|
Re: Insider dealing August
|
3
|
Resverlogix Corp.
|
Sep 01, 2019 10:36AM
|
Re: My one-minute commercial for Apabetalone
|
7
|
Resverlogix Corp.
|
Sep 10, 2019 09:12PM
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 10:08AM
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 10:23AM
|
Re: Tsx 30 news
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 09:53AM
|
Re: Tsx 30 news
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 10:13AM
|
Re: Robing Peter to pay Paul
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 10:40AM
|
Re: proxy vote
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 03:47PM
|
Re: How is Zenith affected by the RVX top line miss
|
4
|
Zenith Epigenetics
|
Sep 30, 2019 07:15PM
|
Re: New Share Price Contest
|
6
|
Resverlogix Corp.
|
Oct 11, 2019 12:28PM
|
Re: I just can’t see the management going
|
6
|
Resverlogix Corp.
|
Oct 29, 2019 09:20AM
|